These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 16151477)
21. Priming of T cells with Ad-transduced DC followed by expansion with peptide-pulsed DC significantly enhances the induction of tumor-specific CD8+ T cells: implications for an efficient vaccination strategy. Tuettenberg A; Jonuleit H; Tüting T; Brück J; Knop J; Enk AH Gene Ther; 2003 Feb; 10(3):243-50. PubMed ID: 12571632 [TBL] [Abstract][Full Text] [Related]
22. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer. Kim S; Lee JB; Lee GK; Chang J Prostate; 2009 Jun; 69(9):938-48. PubMed ID: 19267351 [TBL] [Abstract][Full Text] [Related]
23. Therapeutic tumor immunity induced by polyimmunization with melanoma antigens gp100 and TRP-2. Mendiratta SK; Thai G; Eslahi NK; Thull NM; Matar M; Bronte V; Pericle F Cancer Res; 2001 Feb; 61(3):859-63. PubMed ID: 11221870 [TBL] [Abstract][Full Text] [Related]
24. 'Survival gene' Bcl-xl potentiates DNA-raised antitumor immunity. Kim JH; Chen J; Majumder N; Lin H; Falo LD; You Z Gene Ther; 2005 Oct; 12(20):1517-25. PubMed ID: 16052205 [TBL] [Abstract][Full Text] [Related]
25. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis]. Pan JP; Weng YS; Wu QQ Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366 [TBL] [Abstract][Full Text] [Related]
26. Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice. Okada N; Masunaga Y; Okada Y; Mizuguchi H; Iiyama S; Mori N; Sasaki A; Nakagawa S; Mayumi T; Hayakawa T; Fujita T; Yamamoto A Gene Ther; 2003 Oct; 10(22):1891-902. PubMed ID: 14502218 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic effectiveness of recombinant cancer vaccines is associated with a prevalent T-cell receptor alpha usage by melanoma-specific CD8+ T lymphocytes. De Palma R; Marigo I; Del Galdo F; De Santo C; Serafini P; Cingarlini S; Tüting T; Lenz J; Basso G; Milan G; Zanovello P; Bronte V Cancer Res; 2004 Nov; 64(21):8068-76. PubMed ID: 15520218 [TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant vaccination provides superior protection against tumor relapse following surgery compared with adjuvant vaccination. Grinshtein N; Bridle B; Wan Y; Bramson JL Cancer Res; 2009 May; 69(9):3979-85. PubMed ID: 19383917 [TBL] [Abstract][Full Text] [Related]
29. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity. Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810 [TBL] [Abstract][Full Text] [Related]
30. Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts. Malowany JI; McCormick S; Santosuosso M; Zhang X; Aoki N; Ngai P; Wang J; Leitch J; Bramson J; Wan Y; Xing Z Mol Ther; 2006 Apr; 13(4):766-75. PubMed ID: 16343993 [TBL] [Abstract][Full Text] [Related]
31. Enhancement of tumor lysate- and peptide-pulsed dendritic cell-based vaccines by the addition of foreign helper protein. Shimizu K; Thomas EK; Giedlin M; Mulé JJ Cancer Res; 2001 Mar; 61(6):2618-24. PubMed ID: 11289139 [TBL] [Abstract][Full Text] [Related]
32. Ubiquitin-fusion degradation pathway plays an indispensable role in naked DNA vaccination with a chimeric gene encoding a syngeneic cytotoxic T lymphocyte epitope of melanocyte and green fluorescent protein. Zhang M; Ishii K; Hisaeda H; Murata S; Chiba T; Tanaka K; Li Y; Obata C; Furue M; Himeno K Immunology; 2004 Aug; 112(4):567-74. PubMed ID: 15270727 [TBL] [Abstract][Full Text] [Related]
33. Mannan-modified adenovirus as a vaccine to induce antitumor immunity. Ding ZY; Wu Y; Luo Y; Su JM; Li Q; Zhang XW; Liu JY; He QM; Yang L; Tian L; Zhao X; Deng HX; Wen YJ; Li J; Kang B; Wei YQ Gene Ther; 2007 Apr; 14(8):657-63. PubMed ID: 17287861 [TBL] [Abstract][Full Text] [Related]
34. Combination vaccine of dendritic cells (DCs) and T cells effectively suppressed preestablished malignant melanoma in mice. Asada H; Kishida T; Hirai H; Shin-Ya M; Imanishi J; Takeuchi M; Mazda O Cancer Lett; 2006 Aug; 240(1):83-93. PubMed ID: 16246489 [TBL] [Abstract][Full Text] [Related]